192 related articles for article (PubMed ID: 25277876)
1. Relationship of the Serum CRP Level With the Efficacy of Metformin in the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis.
Shi L; Tan GS; Zhang K
J Clin Lab Anal; 2016 Jan; 30(1):13-22. PubMed ID: 25277876
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes.
Su JR; Lu ZH; Su Y; Zhao N; Dong CL; Sun L; Zhao SF; Li Y
Horm Metab Res; 2016 Feb; 48(2):92-8. PubMed ID: 26808583
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article.
Wang J; Zhu L; Hu K; Tang Y; Zeng X; Liu J; Xu J
Medicine (Baltimore); 2017 Sep; 96(39):e8183. PubMed ID: 28953677
[TBL] [Abstract][Full Text] [Related]
5. Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes.
Fan H; Sun X; Zhang H; Liu J; Zhang P; Xu Y; Pan Q; Wang G
Diabetes Technol Ther; 2016 Mar; 18(3):120-6. PubMed ID: 26950284
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.
Gupta AK; Bray GA; Greenway FL; Martin CK; Johnson WD; Smith SR
J Diabetes Complications; 2010; 24(5):289-96. PubMed ID: 19577936
[TBL] [Abstract][Full Text] [Related]
7. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
[TBL] [Abstract][Full Text] [Related]
8. Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Karbalaee-Hasani A; Khadive T; Eskandari M; Shahidi S; Mosavi M; Nejadebrahimi Z; Khalkhali L; Sangdari A; Mohammadi D; Soltani A; Khodabandehloo H; Hosseini H; Koushki M
Ann Pharmacother; 2021 Sep; 55(9):1096-1109. PubMed ID: 33412927
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
[TBL] [Abstract][Full Text] [Related]
10. The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials.
Hosseini H; Koushki M; Khodabandehloo H; Fathi M; Panahi G; Teimouri M; Majidi Z; Meshkani R
Complement Ther Med; 2020 Mar; 49():102251. PubMed ID: 32147058
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Total Bilirubin Concentration was Associated with Increased High Sensitive C Reactive Protein Level in Patients with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus Subjects.
Zheng J; Wu Y; Li Z; Wang H; Xiao W; Shi Y; Wang T
Clin Lab; 2016; 62(5):901-7. PubMed ID: 27349017
[TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
14. The lost correlation between leptin and CRP in type 2 diabetes.
Morteza A; Nakhjavani M; Asgarani F; Ghaneei A; Esteghamati A; Mirmiranpour H
Eur Cytokine Netw; 2013 Mar; 24(1):53-9. PubMed ID: 23674518
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of Chinese massage as an auxiliary way of replacing or reducing drugs in the clinical treatment of adult type 2 diabetes: A systematic review and meta-analysis.
Zhang X; Cao D; Yan M; Liu M
Medicine (Baltimore); 2020 Aug; 99(34):e21894. PubMed ID: 32846852
[TBL] [Abstract][Full Text] [Related]
16. Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics.
Wu W; Li Q; Xia J; Wang M; Sun Z; Miao J; Zheng Z
Hum Immunol; 2013 Mar; 74(3):379-82. PubMed ID: 23220502
[TBL] [Abstract][Full Text] [Related]
17. Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease.
Fan H; Pan Q; Xu Y; Yang X
Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):702-8. PubMed ID: 24402015
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.
Carter AM; Bennett CE; Bostock JA; Grant PJ
Diabet Med; 2005 Sep; 22(9):1282-4. PubMed ID: 16108864
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis.
Han Y; Xie H; Liu Y; Gao P; Yang X; Shen Z
Cardiovasc Diabetol; 2019 Jul; 18(1):96. PubMed ID: 31362743
[TBL] [Abstract][Full Text] [Related]
20. Effects of Atorvastatin on Serum High-Sensitive C-Reactive Protein and Total Cholesterol Levels in Asian Patients With Atrial Fibrillation.
Wang J; Wang AR; Zhang MJ; Li Y
Am J Ther; 2017; 24(1):e20-e29. PubMed ID: 26566148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
